In lung adenocarcinoma, ALDH2 is highly associated with B cell activity and partial correlation with CD4+ T-cell activity, suggesting that ALDH2 interacts with B cells and T cells in patients with lung adenocarcinoma39. Here, CD4 is linked to lung adenocarcinoma.